July 06, 2012
Novartis Pharmaceuticals Corp. and Merck & Co. Inc. were targeted Friday in two Illinois racketeering class actions alleging the drugmakers interfered with health plan contracts by bribing participants with discounts that unlawfully made prescription plans pay higher prices for name-brand drugs.